Fermentalg
- hard tech
- biotechnology
- horizon europe
- sustainable development goals
- climate tech
- observatoire deeptech
- alternative protein
- bluetech
- blue economy
- agritech
- process technologies
- synthetic biology
- blue biotechnology
- greentech
- energy and greentech
- participations bpifrance
- fermentation
- food as medicine
- enabler of alternative proteins
- algae
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.9m | 2.2m | 5.6m | 7.6m | 4.1m | 11.1m | 16.1m |
| % growth | - | 17 % | 156 % | 35 % | (47 %) | 172 % | 46 % |
| EBITDA | (6.3m) | (8.2m) | (7.7m) | (6.3m) | (8.7m) | (6.4m) | (4.4m) |
| % EBITDA margin | (331 %) | (371 %) | (137 %) | (82 %) | (213 %) | (58 %) | (27 %) |
| Profit | (17.3m) | (6.9m) | (6.8m) | (9.9m) | (14.1m) | (10.2m) | - |
| % profit margin | (916 %) | (312 %) | (121 %) | (129 %) | (347 %) | (92 %) | - |
| EV / revenue | 16.6x | 18.3x | 19.1x | 7.3x | 4.1x | 4.3x | 3.3x |
| EV / EBITDA | -5.0x | -4.9x | -13.9x | -8.9x | -1.9x | -7.4x | -12.1x |
| R&D budget | 3.6m | 4.4m | 3.6m | 4.8m | - | - | - |
| R&D % of revenue | 193 % | 200 % | 64 % | 62 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$2.9m | Seed | ||
€5.3m | Series B | ||
€12.0m | Series C | ||
| N/A | €35.1m Valuation: €102m | IPO | |
* | €12.8m | Post IPO Equity | |
| Total Funding | $21.9m | ||
Related Content
Recent News about Fermentalg
EditFermentalg is a forward-thinking biotechnology company specializing in the development and commercialization of sustainable solutions derived from microalgae. The company operates in the health and nutrition market, focusing on producing vegan omega-3, alternative proteins, natural colors, and clean air solutions. These products cater to a diverse range of clients, including food and beverage manufacturers, dietary supplement producers, and environmental organizations.
Fermentalg's business model revolves around leveraging the natural properties of microalgae to create high-value products. For instance, their DHA ORIGINS range offers a plant-based source of omega-3 fatty acids, which are essential for human health. This product is particularly appealing to the growing segment of consumers seeking vegan and sustainable alternatives to traditional fish oil supplements.
The company generates revenue by selling its innovative microalgae-based products to businesses that incorporate these ingredients into their own offerings. Additionally, Fermentalg collaborates with partners like SUEZ to develop environmental solutions, such as carbon sinks, which help reduce atmospheric CO2 levels. These partnerships not only enhance the company's product portfolio but also open up new revenue streams.
Fermentalg's participation in global events like the ChangeNow Summit in Paris and various trade shows in Geneva, Madrid, and Singapore highlights its commitment to innovation and industry leadership. By showcasing their latest advancements and engaging with potential clients and partners, Fermentalg aims to expand its market presence and drive growth.
In summary, Fermentalg is a pioneering company in the biotechnology sector, offering sustainable microalgae solutions for the food, health, and environmental markets. Its business model focuses on creating high-value products from microalgae, generating revenue through direct sales and strategic partnerships.
Keywords: microalgae, vegan omega-3, alternative proteins, natural colors, clean air, sustainability, biotechnology, health, nutrition, environmental solutions.
